Aquestive Therapeutics (AQST) Current Leases (2020 - 2026)
Aquestive Therapeutics' (AQST) quarterly Current Leases came in at $662000.0 in Q1 2026, up 22.59% year-on-year from $540000.0 in Q1 2025, and up 4.91% quarter-over-quarter from $631000.0 in Q4 2025.
Aquestive Therapeutics (AQST) Current Leases (2020 - 2026) Analysis & Trends
Aquestive Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $662000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 22.59% year-over-year to $662000.0 in Q1 2026; TTM through Mar 2026 was $662000.0, a 22.59% increase from a year earlier, with the FY2025 full-year figure at $631000.0, up 23.73% from the prior year.
- Current Leases improved to $662000.0 in Q1 2026 per AQST's latest filing, from $631000.0 in the prior quarter.
- Across five years, Current Leases topped out at $926000.0 in Q1 2022 and bottomed at $255000.0 in Q4 2022.
- The 5-year median for Current Leases is $510000.0 (2024), against an average of $543352.9.
- Across the five-year window, Current Leases tumbled 71.64% in 2022 and jumped 52.94% in 2023, its largest moves.
- Year by year, Current Leases stood at $255000.0 in 2022, then jumped by 52.94% to $390000.0 in 2023, then jumped by 30.77% to $510000.0 in 2024, then advanced by 23.73% to $631000.0 in 2025, then climbed by 4.91% to $662000.0 in 2026.
- Per Business Quant, the three latest AQST Current Leases figures stand at $662000.0 (Q1 2026), $631000.0 (Q4 2025), and $601000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aquestive Therapeutics | 462.24 Mn | 462.24 Mn | 13.47 Mn | 662,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 662,000.00 |
| Dec 31, 2025 | 631,000.00 |
| Sep 30, 2025 | 601,000.00 |
| Jun 30, 2025 | 570,000.00 |
| Mar 31, 2025 | 540,000.00 |
| Dec 31, 2024 | 510,000.00 |
| Sep 30, 2024 | 482,000.00 |
| Jun 30, 2024 | 455,000.00 |
| Mar 31, 2024 | 414,000.00 |
| Dec 31, 2023 | 390,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 347,000.00 |
| Mar 31, 2023 | 328,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 846,000.00 |
| Jun 30, 2022 | 913,000.00 |
| Mar 31, 2022 | 926,000.00 |
| Dec 31, 2021 | 899,000.00 |
| Sep 30, 2021 | 860,000.00 |
| Jun 30, 2021 | 823,000.00 |